STERIS plc Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent
STERIS plc (STE) reported Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent of 0.60% for the 12-month period ending 2025-03-31, per its 10-K filed 2026-05-29.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch · last filed 2026-05-29
- STERIS plc effective income tax rate reconciliation, tax credit, research, percent for fiscal 2025 was 0.60%, a 14.29% decline from fiscal 2024.
- STERIS plc effective income tax rate reconciliation, tax credit, research, percent for fiscal 2024 was 0.70%, a 75.00% increase from fiscal 2023.
- STERIS plc effective income tax rate reconciliation, tax credit, research, percent for fiscal 2023 was 0.40%, a 42.86% decline from fiscal 2022.
- STERIS plc effective income tax rate reconciliation, tax credit, research, percent for fiscal 2022 was 0.70%, a 40.00% increase from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent 12 month | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent 12 month as first filed |
|---|---|---|
| 2025-03-31 | 0.60% 10-K · filed 2026-05-29 | |
| 2024-03-31 | 0.70% 10-K · filed 2026-05-29 | |
| 2023-03-31 | 0.40% 10-K · filed 2025-05-29 | 1.80% 10-K · filed 2023-05-26 |
| 2022-03-31 | 0.70% 10-K · filed 2024-05-29 | 0.80% 10-K · filed 2022-05-31 |
| 2021-03-31 | 0.50% 10-K · filed 2023-05-26 | |
| 2020-03-31 | 0.50% 10-K · filed 2022-05-31 | |
| 2019-03-31 | 0.60% 10-K · filed 2021-05-28 | |
| 2018-03-31 | 0.50% 8-K · filed 2021-02-09 | |
| 2017-03-31 | 1.10% 10-K · filed 2019-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |